Continuous Kidney Replacement Therapy


Deliver a gentle 24-hour therapy for hemodynamically unstable patients.

Managing critically ill patients is complex. For that reason, the NxStage® System One S with NxView was designed to be simple yet versatile, allowing you to deliver the prescribed dose to your patients whether you choose continuous hemofiltration, hemodialysis, or slow continuous ultrafiltration treatment modalities.

With a uniquely designed volumetric balancing system, fluid accuracy is achieved without the need for scales, completely eliminating scale-based alarms and interruptions in therapy due to emptying waste bags. The ability to hang up to 29 L of fluid at once and direct-to-drain effluent disposal may decrease workload and provides more time for nurses to focus on their patients.

 

Risks and Responsibilities

Kidney replacement therapy, as with any medical therapy is not without risks. The decision of which therapy and medical device to use should be made by the physician, based on previous experience and on the individual facts and circumstances of the patient.

There is no literature demonstrating that one therapy is clinically better than the other.1

The use of anticoagulation is at the discretion of the prescribing physician.

Learn more about how NxStage products and therapies can help you and your patients.

Related Products

References

  1. Kraus MA. Selection of Dialysate and replacement fluids and management of electrolyte and acid-base disturbances. Semin Dial 2009;22(2):137-140

 

© 2024 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, NxStage, NxView, System One, and PureFlow are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners. APM2078 Rev. F